Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Peritoneal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01685255
What this trial is testing

The IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy

Who this might be right for
Ovarian CancerGenitourinary (GU) Tumors
Incyte Corporation 83
Not applicableLooking for participantsNCT05718726
What this trial is testing

Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI)

Who this might be right for
Infection;Post Surg ProcedurePeritoneal Cancer
Hampshire Hospitals NHS Foundation Trust 300
Not applicableStudy completedNCT02325648
What this trial is testing

The Intraoperative Physiologic Changes of Patients Under Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Cytoreductive Surgery; Prospective Observational Study

Who this might be right for
Peritoneal Surface Malignancies
Yonsei University 22
Testing effectiveness (Phase 2)Study completedNCT00019552
What this trial is testing

Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04462809
What this trial is testing

Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma

Who this might be right for
Advanced Malignant Pleural or Peritoneal Mesothelioma
Hospices Civils de Lyon 40
Testing effectiveness (Phase 2)Study completedNCT00072566
What this trial is testing

Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal CarcinomaRecurrent Ovarian CarcinomaStage IV Ovarian Cancer
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT02324595
What this trial is testing

Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study

Who this might be right for
Stage IV Ovarian CarcinomaEffects of ChemotherapyPeritoneal Cavity Cancer
Catholic University of the Sacred Heart 30
Early research (Phase 1)Ended earlyNCT00003382
What this trial is testing

Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00010179
What this trial is testing

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 81
Large-scale testing (Phase 3)Ended earlyNCT00047632
What this trial is testing

Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer

Who this might be right for
Ovarian CarcinomaPeritoneal Carcinoma
InterMune 847
Early research (Phase 1)Looking for participantsNCT07489287
What this trial is testing

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer
Roswell Park Cancer Institute 18
Not applicableStudy completedNCT01823107
What this trial is testing

Feasibility Study of Meso BioMatrix Device for Breast Reconstruction

Who this might be right for
Breast Cancer
Kensey Nash Corporation 25
Not applicableUnknownNCT00958698
What this trial is testing

Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaPsychological Impact of Cancer+1 more
Gynecologic Oncology Group 485
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554328
What this trial is testing

Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+1 more
National Cancer Institute (NCI) 165
Not applicableStudy completedNCT02823860
What this trial is testing

Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies

Who this might be right for
Digestive Peritoneal Carcinomatosis
Hospices Civils de Lyon 2,186
Not applicableStudy completedNCT02356471
What this trial is testing

Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery

Who this might be right for
Malignant Gastrointestinal NeoplasmMalignant Peritoneal Neoplasm
Wake Forest University Health Sciences 34
Early research (Phase 1)Study completedNCT02324439
What this trial is testing

Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Southern Illinois University 15
Early research (Phase 1)Study completedNCT01219777
What this trial is testing

Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

Who this might be right for
Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
Ritu Salani 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT02345265
What this trial is testing

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer

Who this might be right for
Fallopian Tube CarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Serous Adenocarcinoma+6 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00097019
What this trial is testing

Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed

Who this might be right for
Ovarian Cancer
Genentech, Inc. 53
Next Page